m72
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 17, 2020 (NCT04556981)
Timeline
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06062238 | Phase 3 | Feb 29, 2024 | Bill and Melinda Gates Foundation, Wellcome Trust |
| NCT04556981 | Phase 2 | Nov 17, 2020 | Bill and Melinda Gates Foundation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 2 | 2 | 2 | 2020 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1